4 Analysts Have This to Say About Amylyx Pharma
Portfolio Pulse from Benzinga Insights
Over the past three months, four analysts have published bullish opinions on Amylyx Pharma (NASDAQ:AMLX) stock. The average price target given by these analysts is $49.75, which is significantly higher than the current price of $22.55. This average has increased by 2.58% from the previous average price target of $48.50.
July 24, 2023 | 12:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Amylyx Pharma (NASDAQ:AMLX) has received bullish ratings from four analysts over the past three months. The average price target given is $49.75, indicating a potential upside from the current price of $22.55.
The bullish ratings and the high average price target given by the analysts indicate a positive outlook for Amylyx Pharma. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100